Mark Anderson
Executive Vice President for Medical Affairs, Dean of the Division of the Biological Sciences, and Dean of the Pritzker School of Medicine
University of Chicago Medical Center
5841 S. Maryland Avenue, MC 1000
Chicago, IL 60637
Phone: 773.702.3004
Fax: 773.702.1897
andersonm1@bsd.uchicago.edu
Executive Assistant:
Melissa (Mel) Stephens
773.702.6240
Melissa.Stephens@uchicagomedicine.org
Mark E. Anderson, MD, PhD, is a globally recognized physician-scientist and academic leader who has served as dean of the Biological Sciences Division and the Pritzker School of Medicine and executive vice resident for Medical Affairs at the University of Chicago since 2022. In these roles, he leads the University’s integrated academic health and research enterprise, bringing together pioneering biomedical research, transformative medical education, and world-class clinical care to advance discovery, improve health, and expand access to care across Chicago’s South Side and beyond.
Early in his tenure, Dr. Anderson established a joint Mission, Vision and Values statement to create greater alignment across the Biological Sciences Division, the Pritzker School of Medicine and the UChicago Medicine health system, which make up the academic health and research enterprise. More recently, under his direction, the first unified strategic plan spanning the three parts of the organization was developed. The plan, called Elevate 2035, aligns research, education, and clinical care to accelerate biological and biomedical discovery across the University, cultivate future physicians and scientists, and expand access to high-quality healthcare.
During Dr. Anderson’s tenure, UChicago Medicine has expanded significantly in both scale and reach across Chicago, the western suburbs, and Northwest Indiana. Health system operating revenue has grown over 68 percent, totaling $6.4 billion, while operating revenue for the Biological Sciences Division has increased 34 percent, totaling $1.8 billion. Health system growth includes construction of the AbbVie Foundation Cancer Pavilion, a 575,000-square-foot, seven-story facility that will become Illinois’ first freestanding cancer care and research facility when it opens in April 2027. Investment in the South Side continues with plans to build new pathology laboratories and medical technologist training facilities in Washington Park. In addition, he helped shape the development of laboratory space at Hyde Park Labs, a new commercial facility on Chicago’s South Side designed to accelerate scientific discovery and biomedical entrepreneurship.
A pioneering researcher in cardiovascular medicine, Dr. Anderson is known for his seminal work on the role of an enzyme called calmodulin-dependent protein kinase II (CaMKII) in cardiac arrhythmias and heart failure—leading causes of sudden cardiac death worldwide. His discoveries about CaMKII’s molecular mechanisms have opened new avenues to treat heart and other diseases.
Anderson came to the leadership at UChicago in October 2022 from the Johns Hopkins University School of Medicine, where he served as director of the Department of Medicine, the William Osler Professor of Medicine, and physician-in-chief of the Johns Hopkins Hospital. His prior leadership roles include chairing the Department of Internal Medicine and directing the Cardiovascular Research Center at the University of Iowa, as well as key faculty positions at Vanderbilt University.
Dr. Anderson earned a Bachelor of Arts in Biology with honors from Macalester College and a Doctor of Medicine and a Doctor of Philosophy in Physiology from the University of Minnesota. He completed his residency in internal medicine, postdoctoral research training, and fellowships in cardiology and clinical cardiac electrophysiology at Stanford University. Research by the Anderson laboratory has been recognized by a variety of awards, including the Distinguished Scientist Awards from the American Heart Association and the Heart Rhythm Society, and the Research Achievement Award from the International Society of Heart Research. He is an elected member of the American Society for Clinical Investigation, the Association of American Physicians, and the National Academy of Medicine.